NXTC
NextCure Inc.
$5.56
-$0.08(-1.42%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$15.09M
Volume
3.90K
52W Range
$0.22 - $6.42
Target Price
$17.50
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $6.3M | $22.4M | -- | -- | -- | -- | ||
| Total Revenue | $6.3M | $22.4M | -- | -- | -- | -- | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $6.3M | $22.4M | -- | -- | -- | -- | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $-43.8M | $63.6M | $70.8M | $75.9M | $67.6M | $59.7M | ||
| Research & Development | $34.2M | $46.6M | $50.2M | $54.2M | $47.9M | $41.5M | ||
| Research Expense | $34.2M | $46.6M | $50.2M | $54.2M | $47.9M | $41.5M | ||
| Selling, General & Administrative | $9.6M | $17.0M | $20.6M | $21.7M | $19.7M | $15.7M | ||
| General & Administrative Expenses | $9.6M | $17.0M | $20.6M | $21.7M | $19.7M | $15.7M | ||
| Salaries & Wages | $-1.9M | -- | -- | -- | $8.2M | $6.3M | ||
| Depreciation & Amortization | $-2.7M | $3.4M | $4.3M | $4.1M | $3.7M | $2.9M | ||
| Depreciation & Amortization | $-2.7M | $3.4M | $4.3M | $4.1M | $3.7M | $2.9M | ||
| Other Operating Expenses | -- | -- | -- | $1.0M | $1.1M | $1.0M | ||
| OPERATING INCOME | ||||||||
| Operating income | $-37.5M | $-41.2M | $-70.8M | $-75.9M | $-67.6M | $-59.7M | ||
| EBITDA | $-31.2M | $-37.8M | $-66.6M | $-67.6M | $-59.0M | $-52.8M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $-209.0K | $183.0K | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $209.0K | $-183.0K | -- | -- | -- | -- | ||
| Gain on Sale of Securities | -- | $70.0K | $57.0K | $9.0K | -- | -- | ||
| Other Income/Expense | $-3.7M | $-4.6M | $-1.4M | $-1.2M | $-4.9M | $-4.1M | ||
| Other Special Charges | $3.7M | $4.6M | $1.4M | $1.2M | $4.9M | $4.1M | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | $2.5M | ||
| Special Income Charges | -- | -- | -- | -- | -- | $-2.5M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $1.8M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-33.9M | $-41.2M | $-70.8M | $-74.7M | $-62.7M | $-55.7M | ||
| Pre-Tax Income | $-33.7M | $-36.6M | $-69.4M | $-74.7M | $-62.7M | $-55.7M | ||
| NET INCOME | ||||||||
| Net Income | $-33.7M | $-36.6M | $-69.4M | $-74.7M | $-62.7M | $-55.7M | ||
| Net Income (Continuing Operations) | $-33.7M | $-36.6M | $-69.4M | $-74.7M | $-62.7M | $-55.7M | ||
| Net Income (Discontinued Operations) | $-33.7M | $-36.6M | $-69.4M | $-74.7M | $-62.7M | $-55.7M | ||
| Net Income (Common Stockholders) | $-33.7M | $-36.6M | $-69.4M | $-74.7M | $-62.7M | $-55.7M | ||
| Normalized Income | -- | -- | $-54.8M | $-59.0M | -- | $-49.6M | ||
| TOTALS | ||||||||
| Total Expenses | $-43.8M | $63.6M | $70.8M | $75.9M | $67.6M | $59.7M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $1.3M | $2.3M | $2.3M | $27.7M | $2.3M | $28.0M | ||
| Average Shares Outstanding (Diluted) | $1.3M | $2.3M | $2.3M | $27.7M | $2.3M | $28.0M | ||
| Shares Outstanding | $2.3M | $2.3M | $2.3M | $27.8M | $2.3M | $28.0M | ||
| Basic EPS | -- | $-15.96 | $-30.12 | $-2.69 | $-27 | $-1.99 | ||
| Basic EPS (Continuing Operations) | -- | $-15.96 | $-30.12 | $-2.69 | $-27 | $-1.99 | ||
| Diluted EPS | $-25.8 | $-15.96 | $-30.12 | $-2.69 | $-27 | $-1.99 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-30.12 | $-2.69 | $-27 | $-1.99 | ||
| OTHER METRICS | ||||||||
| Other Gand A | $9.6M | $17.0M | $20.6M | $21.7M | $19.7M | $15.7M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | $1.2M | ||
| Rent And Landing Fees | $9.6M | $900.0K | $1.0M | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | $2.5M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NXTC | $5.56 | -1.4% | 3.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |